Peripheral venous thrombus

A peripheral venous thrombus is a blood clot in a vein outside the central circulatory system, usually forming in the deep veins of the legs (as in deep vein thrombosis, DVT), arms, or, less commonly, superficial veins. It is a central feature of diseases like venous thromboembolism (VTE) and can lead to life-threatening complications such as pulmonary embolism if parts of the clot dislodge and travel to the lungs[6][7][9]. The mechanism of thrombus formation involves interactions between blood components (clotting factors and platelets), vessel wall injury, and slowed blood flow (Virchow's triad)[6][9]. "Peripheral venous thrombus" is a pathological event, not a specific molecular target or receptor. Therapeutic targets are specific molecules (e.g., thrombin, factor Xa) or structures (platelet glycoprotein receptors) involved in this process, but not the thrombus as such. In summary: Peripheral venous thrombus is a clinical-pathological entity, not a therapeutic target, protein, or receptor molecule. While it is the outcome of many molecular processes (coagulation cascade, platelet activation, endothelial dysfunction), the term does not refer to a druggable target. Drugs like anticoagulants (e.g., heparin, warfarin, direct oral anticoagulants) act by inhibiting key molecules in the clotting pathway, not the "thrombus" itself[6][7][9].

Other names

Peripheral venous clotVenous thrombus (peripheral)Peripheral deep vein thrombosis (if deep veins involved)Peripheral venous thrombosis

Therapeutic interventions, such as anticoagulants, inhibit molecular regulators of clotting (e.g., thrombin, factor Xa, or platelet receptors) to prevent or treat thrombus formation, rather than acting on the thrombus itself. These drugs target the molecular processes leading to the formation of the thrombus.